
    
      To identify predictors of the magnitude and trajectory of response to flexibly-dosed
      duloxetine and escitalopram response in adolescents with anxiety, including those with
      depressive symptoms. And also to examine long-term predictors of sustained response and
      relapse in adolescents. To examine predictors of developing depressive disorders in anxious
      adolescents.
    
  